Qiagen NV (QGEN)
43.26
+0.62
(+1.45%)
USD |
NYSE |
May 31, 16:00
43.29
+0.03
(+0.07%)
After-Hours: 20:00
Qiagen Gross Profit (TTM): 1.217B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.217B |
December 31, 2023 | 1.234B |
September 30, 2023 | 1.235B |
June 30, 2023 | 1.258B |
March 31, 2023 | 1.277B |
December 31, 2022 | 1.385B |
September 30, 2022 | 1.441B |
June 30, 2022 | 1.457B |
March 31, 2022 | 1.495B |
December 31, 2021 | 1.451B |
September 30, 2021 | 1.450B |
June 30, 2021 | 1.434B |
March 31, 2021 | 1.360B |
December 31, 2020 | 1.233B |
September 30, 2020 | 1.139B |
June 30, 2020 | 1.073B |
March 31, 2020 | 1.024B |
December 31, 2019 | 1.005B |
September 30, 2019 | 990.45M |
June 30, 2019 | 992.28M |
March 31, 2019 | 1.000B |
December 31, 2018 | 1.001B |
September 30, 2018 | 997.48M |
June 30, 2018 | 981.59M |
March 31, 2018 | 952.39M |
Date | Value |
---|---|
December 31, 2017 | 922.56M |
September 30, 2017 | 889.29M |
June 30, 2017 | 869.47M |
March 31, 2017 | 855.72M |
December 31, 2016 | 844.65M |
September 30, 2016 | 840.24M |
June 30, 2016 | 823.83M |
March 31, 2016 | 813.56M |
December 31, 2015 | 826.66M |
September 30, 2015 | 819.10M |
June 30, 2015 | 837.63M |
March 31, 2015 | 852.96M |
December 31, 2014 | 865.21M |
September 30, 2014 | 885.02M |
June 30, 2014 | 872.55M |
March 31, 2014 | 825.60M |
December 31, 2013 | 815.49M |
September 30, 2013 | 812.15M |
June 30, 2013 | 800.61M |
March 31, 2013 | 834.67M |
December 31, 2012 | 824.02M |
September 30, 2012 | 793.22M |
June 30, 2012 | 781.60M |
March 31, 2012 | 767.03M |
December 31, 2011 | 749.81M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
990.45M
Minimum
Sep 2019
1.495B
Maximum
Mar 2022
1.258B
Average
1.247B
Median
Gross Profit (TTM) Benchmarks
MoonLake Immunotherapeutics | -- |
LENZ Therapeutics Inc | -- |
Thermo Fisher Scientific Inc | 17.16B |
uniQure NV | -1.416M |
ProQR Therapeutics NV | -- |